Finance

Lists
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹23.65
-2.43%
(-0.59) 1D
Sep 8, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹24.24
High
₹24.75
Low
₹23.20
Mkt. cap
1.29B
Avg. vol.
0.00
Volume
67.89K
P/E ratio
53.49
52-wk high
₹47.75
52-wk low
₹15.20
EPS
₹0.44
No. of employees
500
Open
₹24.24
High
₹24.75
Low
₹23.20
Mkt. cap
1.29B
Avg. vol.
0.00
Volume
67.89K
P/E ratio
53.49
52-wk high
₹47.75
52-wk low
₹15.20
EPS
₹0.44
No. of employees
500
About Balaxi Pharmaceuticals Ltd
CEO-
Employees500
Founded1942
Headquarters-
SectorHealth care provider
Websitebalaxipharma.in
Last report
Aug 5, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
806.82M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
561.75M
725.42M
707.14M
806.82M
Cost of goods sold
290.29M
417.35M
414.90M
431.74M
Cost of revenue
290.29M
417.35M
414.90M
431.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259.77M
277.18M
291.02M
328.46M
Operating expense
264.62M
282.77M
297.48M
336.94M
Total operating expenses
554.91M
700.12M
712.38M
768.68M
Operating income
6.84M
25.30M
-5.25M
38.14M
Other non operating income
15.85M
957.00K
18.30M
-9.92M
EBT including unusual items
13.77M
16.10M
14.03M
20.89M
EBT excluding unusual items
13.77M
16.10M
12.99M
20.89M
Income tax expense
11.68M
13.05M
7.90M
7.92M
Effective tax rate
84.82%
81.05%
56.31%
37.90%
Other operating expenses
-
-
-
-
Net income
2.09M
3.05M
6.13M
12.97M
Net profit margin
0.37%
0.42%
0.87%
1.61%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-8.92M
-10.16M
-9.90M
-7.33M
Net interest expenses
-8.92M
-10.16M
-9.90M
-7.33M
Depreciation and amortization charges
4.84M
5.60M
6.46M
8.48M
EBITDA
11.58M
29.57M
-328.75K
43.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps